Logo image of CANS.CA

WILDPACK BEVERAGE INC (CANS.CA) Stock Fundamental Analysis

TSX-V:CANS - TSX Venture Exchange - CA96812Y1016 - Common Stock - Currency: CAD

0.005  0 (0%)

Fundamental Rating

1

CANS gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 13 industry peers in the Beverages industry. CANS may be in some trouble as it scores bad on both profitability and health. CANS has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CANS had negative earnings in the past year.
CANS had a negative operating cash flow in the past year.
In the past 5 years CANS always reported negative net income.
CANS had a negative operating cash flow in each of the past 5 years.
CANS.CA Yearly Net Income VS EBIT VS OCF VS FCFCANS.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

CANS's Return On Assets of -121.50% is on the low side compared to the rest of the industry. CANS is outperformed by 61.54% of its industry peers.
Industry RankSector Rank
ROA -121.5%
ROE N/A
ROIC N/A
ROA(3y)-79.88%
ROA(5y)-56.87%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CANS.CA Yearly ROA, ROE, ROICCANS.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 200 -200 400

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CANS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CANS.CA Yearly Profit, Operating, Gross MarginsCANS.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

More info and screens

0

2. Health

2.1 Basic Checks

CANS does not have a ROIC to compare to the WACC, probably because it is not profitable.
CANS has about the same amout of shares outstanding than it did 1 year ago.
CANS has a worse debt/assets ratio than last year.
CANS.CA Yearly Shares OutstandingCANS.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
CANS.CA Yearly Total Debt VS Total AssetsCANS.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of -7.40, we must say that CANS is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -7.40, CANS is doing worse than 61.54% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -7.4
ROIC/WACCN/A
WACC0.18%
CANS.CA Yearly LT Debt VS Equity VS FCFCANS.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 20M -20M -40M -60M

2.3 Liquidity

CANS has a Current Ratio of 0.14. This is a bad value and indicates that CANS is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.14, CANS is doing worse than 76.92% of the companies in the same industry.
A Quick Ratio of 0.10 indicates that CANS may have some problems paying its short term obligations.
CANS's Quick ratio of 0.10 is on the low side compared to the rest of the industry. CANS is outperformed by 76.92% of its industry peers.
Industry RankSector Rank
Current Ratio 0.14
Quick Ratio 0.1
CANS.CA Yearly Current Assets VS Current LiabilitesCANS.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

2

3. Growth

3.1 Past

CANS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -110.62%.
Looking at the last year, CANS shows a decrease in Revenue. The Revenue has decreased by -1.75% in the last year.
Measured over the past years, CANS shows a very strong growth in Revenue. The Revenue has been growing by 25.06% on average per year.
EPS 1Y (TTM)-110.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-101.62%
Revenue 1Y (TTM)-1.75%
Revenue growth 3Y25.06%
Revenue growth 5YN/A
Sales Q2Q%3.32%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y150%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year48.33%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CANS.CA Yearly Revenue VS EstimatesCANS.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 50M 100M 150M
CANS.CA Yearly EPS VS EstimatesCANS.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 0 -0.1 -0.2 -0.3

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CANS. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 0.12 indicates a rather cheap valuation of CANS.
Based on the Price/Forward Earnings ratio, CANS is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of CANS to the average of the S&P500 Index (22.19), we can say CANS is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 0.12
CANS.CA Price Earnings VS Forward Price EarningsCANS.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CANS.CA Per share dataCANS.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

CANS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CANS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WILDPACK BEVERAGE INC

TSX-V:CANS (6/18/2025, 7:00:00 PM)

0.005

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)05-06 2025-05-06/amc
Earnings (Next)N/A N/A
Inst Owners5.95%
Inst Owner ChangeN/A
Ins Owners27.88%
Ins Owner ChangeN/A
Market Cap500.90K
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-50.56%
Min Revenue beat(2)-58.33%
Max Revenue beat(2)-42.79%
Revenue beat(4)0
Avg Revenue beat(4)-49.25%
Min Revenue beat(4)-58.33%
Max Revenue beat(4)-42.79%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.12
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.7
EYN/A
EPS(NY)0.04
Fwd EY821.83%
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS0.75
BVpS-0.98
TBVpS-1.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -121.5%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-79.88%
ROA(5y)-56.87%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover1.3
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 3.24%
Cap/Sales 0.38%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.14
Quick Ratio 0.1
Altman-Z -7.4
F-Score2
WACC0.18%
ROIC/WACCN/A
Cap/Depr(3y)16.37%
Cap/Depr(5y)54.85%
Cap/Sales(3y)1.96%
Cap/Sales(5y)6.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-110.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-101.62%
EPS Next Y150%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.75%
Revenue growth 3Y25.06%
Revenue growth 5YN/A
Sales Q2Q%3.32%
Revenue Next Year48.33%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-33.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1399.22%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y53.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y48.27%
OCF growth 3YN/A
OCF growth 5YN/A